510(k) Report

510(k) · Cleared

Cleared

Audit Microcv Tumor Markers Linearity Set, Model K719M-5

K082717510(k) TraditionalCleared Oct 30, 200843-day reviewClass I21 CFR 862.1660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Aalto Scientific, Ltd. · JJY Multi-Analyte Controls, All Kinds (Assayed)

Cleared on Oct 30, 2008 as substantially equivalent to K042318 (Aalto Scientific, Ltd., 2004) after a 43-day review. Its family tree reaches back 3 generations to 1991. 1 later device descends from it.

Decided
Oct 30, 2008
Review
43 days
Class
Class I
Product code
JJY
Recalls
None
Predicates
1

Its longest line of descent runs back 3 generations to K910440 (1991). 1 later device descends from it, 1 citing it directly.

  1. Root · 3 generations backK910440 Document Reflectance II Linearity Test SetCasco Standards · 1991
  2. 2 generations backK023410 Validate Chem 10 Calibration Verification Test Set, Model 110Maine Standards Co. · 2003
  3. 1 generation backK042318 Audit Microcv General Chemistry Linearity SetAalto Scientific, Ltd. · 2004
  4. This deviceK082717 Audit Microcv Tumor Markers Linearity Set, Model K719M-5Aalto Scientific, Ltd. · 2008
  5. Descendant · cites it directly · 0 of its ownK143573 Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd. · 2015

Most influential descendants

Showing 1 of 1 · See all
  • K143573Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd. · 2015 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−3K910440Document Reflectance II Linearity Test SetCasco Standards1991—
−2K023410Validate Chem 10 Calibration Verification Test Set, Model 110Maine Standards Co.2003—
−1K042318Audit Microcv General Chemistry Linearity SetAalto Scientific, Ltd.2004—
0 (this device)K082717Audit Microcv Tumor Markers Linearity Set, Model K719M-5Aalto Scientific, Ltd.2008—
+1K143573Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.2015—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201510
FIG. 1 — Lineage of K082717, 1991–2015Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in JJY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042318Audit Microcv General Chemistry Linearity Set
Summary page 1
…JJY E. Device to Which Substantial Equivalence is Claimed AuditTM MicroCVTM General Chemistry Linearity Set Aalto Scientific, Ltd., Carlsbad, CA K042318 Page 3 of 17 A 4alto Scientific, Li…
Aalto Scientific, Ltd.2004—

Also cleared against K042318: 11 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K143573Audit MicroControls Linearity FD Tumor Markers IIAalto Scientific, Ltd.20150

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 17 years and passes through 3 companies; a new generation was cleared every 3.9 years on median.
  • None of the 3 ancestors has a recall.
  • Of its descendants, K143573 (Aalto Scientific, Ltd., 2015) has gone furthest, with 0 descendants of its own.
  • 11 other devices also cite its predicate K042318.

How does its category compare?

All JJY devices

JJY Multi-Analyte Controls, All Kinds (Assayed): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · JJY

3in 2017

2007: 112008: 72009: 82010: 102011: 142012: 132013: 162014: 102015: 42016: 12017: 3
2007high 16 (2013) · low 0 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · JJY

78in 2017

2007: 49 days median2008: 54 days median2009: 80 days median2010: 109 days median2011: 120 days median2012: 40 days median2013: 82 days median2014: 49 days median2015: 153 days median2017: 78 days median
2007high 153 (2015) · low 40 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · JJY

2in 2025

2007: 52009: 22010: 62011: 12012: 32013: 22014: 22015: 12016: 32017: 42018: 32019: 42020: 62022: 32023: 32025: 22026 (partial year): 1
2007high 6 (2010) · low 0 (2008)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · JJY

13in 2025

2007: 22008: 12009: 32010: 32011: 62012: 202013: 52014: 42015: 42016: 132017: 122018: 72019: 12020: 72021: 12023: 42024: 12025: 13
2007high 20 (2012) · low 0 (2022)2025

MAUDE reports naming product code JJY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007114952
200875401
200988023
20101010963
20111412016
20121340320
2013168225
2014104924
2015415314
20161—313
2017378412
20180—37
20190—41
20200—67
20210—01
20220—30
20230—34
20240—01
20250—213
20260—1—

What is it indicated for?

The AuditTM MicroCVTM Tumor Markers Linearity Set consists of five levels in Human based serum. Each level contains the following analytes: Alpha fetoprotein (AFP), Carcinoembryonic antigen (CEA), CA 125, CA 15-3, Prostate specific antigen-free (free PSA), total PSA. The five levels demonstrate a linear relationship to each other for their respective analytes, reagents, and instruments. This product may be used for proficiency testing in interlaboratory surveys.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082717: Audit Microcv Tumor Markers Linearity Set, Model K719M-5.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K082717

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026